Startup · $1.6m raised · Healthcare · AI
AI-powered oncology platform for precise chemotherapy dosing
Melbourne, VIC
Every investor coverage indicates participated in a round PredicTx raised.
| Investor | Rounds | Invested |
|---|---|---|
| Genesis Fund | Pre-seed | - |
| Genesis Pre-Seed Fund | Pre-seed | - |
Companies PredicTx acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming PredicTx. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Wholesale Investor's news listing spanning Australian private capital: deep-tech and biotech company profiles, property and crypto commentary, Q1 2026 venture funding totals, and guides to wholesale investor qualification.
A University of Melbourne spin-out using AI to tailor chemotherapy doses has banked pre-seed capital from the university's Genesis fund, plus public grant money and angels, to commercialise its oncology platform.